PCRX R&D Expenses
$121.73MTTM · USD
Period ending:
PCRX FY R&D ExpensesUSD
$117.31M$0.00
2008-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
PCRX r&d expenses history
Research and development spending. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.
| Period ending | R&D Expenses (USD) |
|---|---|
| 117,312,000 | |
| 81,577,000 | |
| 76,257,000 | |
| 84,797,000 | |
| 55,545,000 | |
| 59,421,000 | |
| 72,119,000 | |
| 55,688,000 | |
| 57,290,000 | |
| 45,678,000 | |
| 28,662,000 | |
| 18,731,000 | |
| 21,560,000 | |
| 9,937,000 | |
| 14,873,000 | |
| 18,628,000 | |
| 26,233,000 | |
| 33,214,000 |
Compare r&d expenses
All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics
